Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 23 October 2008, doi:10.1136/bmj.a1938
Cite this as: BMJ 2008;337:a1938
Jon C Tilburt, staff scientist1, Ezekiel J Emanuel, director1, Ted J Kaptchuk, associate director2, Farr A Curlin, assistant professor of medicine3, Franklin G Miller, director, research ethics programme1
1 Department of Bioethics, National Institutes of Health, Bethesda, MD 20892, USA , 2 Osher Institute, Harvard Medical School, 401 Park Dr, Boston, MA 02215, 3 Section of Internal Medicine and the McClean Center for Clinical Medical Ethics, University of Chicago, 5841 S Maryland Ave, MC 2007 Chicago, IL 60637
Correspondence to: J Tilburt tilburt.jon{at}mayo.edu
Design Cross sectional mailed survey.
Setting Physicians clinical practices.
Participants 1200 practising internists and rheumatologists in the United States.
Main outcome measures Investigators measured physicians self reported behaviours and attitudes concerning the use of placebo treatments, including measures of whether they would use or had recommended a "placebo treatment," their ethical judgments about the practice, what they recommended as placebo treatments, and how they typically communicate with patients about the practice.
Results 679 physicians (57%) responded to the survey. About half of the surveyed internists and rheumatologists reported prescribing placebo treatments on a regular basis (46-58%, depending on how the question was phrased). Most physicians (399, 62%) believed the practice to be ethically permissible. Few reported using saline (18, 3%) or sugar pills (12, 2%) as placebo treatments, while large proportions reported using over the counter analgesics (267, 41%) and vitamins (243, 38%) as placebo treatments within the past year. A small but notable proportion of physicians reported using antibiotics (86, 13%) and sedatives (86, 13%) as placebo treatments during the same period. Furthermore, physicians who use placebo treatments most commonly describe them to patients as a potentially beneficial medicine or treatment not typically used for their condition (241, 68%); only rarely do they explicitly describe them as placebos (18, 5%).
Conclusions Prescribing placebo treatments seems to be common and is viewed as ethically permissible among the surveyed US internists and rheumatologists. Vitamins and over the counter analgesics are the most commonly used treatments. Physicians might not be fully transparent with their patients about the use of placebos and might have mixed motivations for recommending such treatments.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati
Twitter What's this?
Read all Rapid Responses